文献速递运动医学关节外科

膝关节基质诱导自体软骨细胞植入术后至少10年结局:系统综述

Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee: A Systematic Review.
PubMed 文献 · Am J Sports Med · 2024-02-05

本系统综述纳入168例患者(188个软骨缺损)接受膝关节基质诱导自体软骨细胞植入术(MACI)并随访至少10年的研究,显示患者报告结局(PROs)有显著且持久的长期改善,全因再手术率9.0%,10至17年随访期间进展至全膝关节置换术(TKA)的总体率为7.4%。作者认为这些数据支持MACI作为膝关节局灶性软骨缺损的长期治疗方法。

要点

  • MACI术后至少10年随访中,多项患者报告结局(PROs)指标显示显著且持久的长期改善。
  • 随访磁共振成像(MRI)显示多数患者缺损填充满意且移植物完整。
  • 全因再手术率为9.0%,10至17年随访期间进展至全膝关节置换术(TKA)的总体率为7.4%。

核心结论

  • 至少10年随访时,接受MACI治疗膝关节软骨缺损的患者在患者报告结局(PROs)方面表现出显著且持久的改善,基于MRI评估的缺损填充满意,再手术率和全膝关节置换术(TKA)率低。
  • 作者认为这些数据支持MACI作为膝关节局灶性软骨缺损的长期治疗方法。

研究设计与样本

  • 系统综述,证据等级为4级。
  • 检索Ovid MEDLINE及Epub Ahead of Print、In-Process & Other Non-Indexed Citations and Daily、Ovid Embase、Ovid Cochrane Central Register of Controlled Trials、Ovid Cochrane Database of Systematic Reviews和Scopus,检索时间范围为2008年至2022年9月15日,语言限定为英语。
  • 纳入标准包括:(1)英文全文文章;(2)接受膝关节内MACI的患者;(3)报告临床结局;(4)至少10年随访。
  • 共纳入168例患者(99例男性,69例女性;平均年龄37岁[范围15-63岁];平均体重指数26.2[范围18.6-39.4]),代表188个接受治疗的软骨缺损,随访至少10年。

主要发现

  • 在多项患者报告结局(PROs)指标中观察到显著且持久的长期改善。
  • 随访磁共振成像(MRI)检查时,多数患者显示满意的缺损填充和完整的移植物。
  • 全因再手术率为9.0%,10至17年随访期间进展至全膝关节置换术(TKA)的总体率为7.4%。

临床怎么用

  • 作者认为这些数据支持MACI作为膝关节局灶性软骨缺损的长期治疗方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Matrix-induced autologous chondrocyte implantation (MACI) is an established cell-based therapy for the treatment of chondral defects of the knee. As long-term outcomes are now being reported in the literature, it is important to systematically review available evidence to better inform clinical practice. PURPOSE: To report (1) subjective patient-reported outcomes (PROs) and (2) the rate of graft failure, reoperation, and progression to total knee arthroplasty (TKA) after undergoing MACI of the knee at a minimum 10-year follow-up. STUDY DESIGN: Systematic review; Level of evidence, 4. METHODS: A comprehensive search of Ovid MEDLINE and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily; Ovid Embase; Ovid Cochrane Central Register of Controlled Trials; Ovid Cochrane Database of Systematic Reviews; and Scopus from 2008 to September 15, 2022, was conducted in the English language. Study eligibility criteria included (1) full-text articles in the English language, (2) patients undergoing a MACI within the knee, (3) clinical outcomes reported, and (4) a minimum 10-year follow-up. RESULTS: In total, 168 patients (99 male, 69 female; mean age, 37 years [range, 15-63 years]; mean body mass index, 26.2 [range, 18.6-39.4]) representing 188 treated chondral defects at a minimum 10-year follow-up after MACI were included in this review. Significant and durable long-term improvements were observed across multiple PRO measures. Follow-up magnetic resonance imaging (MRI), when performed, also demonstrated satisfactory defect fill and an intact graft in the majority of patients. The all-cause reoperation rate was 9.0%, with an overall 7.4% rate of progression to TKA at 10 to 17 years of follow-up. CONCLUSION: At a minimum 10-year follow-up, patients undergoing MACI for knee chondral defects demonstrated significant and durable improvements in PROs, satisfactory defect fill on MRI-based assessment, and low rates of reoperation and TKA. These data support the use of MACI as a long-term treatment of focal cartilage defects of the knee.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Wang AS, Nagelli CV, Lamba A, et al. Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee: A Systematic Review. Am J Sports Med. 2024. PMID: 38312085. doi:10.1177/03635465231205309

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。